Press Release: Mergers: Commission approves acquisition of pharmaceutical supplier Capsugel by US investment fund KKR

The European Commission has cleared under the EU Merger Regulation the proposed acquisition of Capsugel by fund manager KKR. Capsugel manufactures dosage delivery products, such as hard gelatine capsules used for pharmaceutical products. The Commission's investigation showed that no horizontal overlaps arise from the transaction, since neither KKR nor any company that it controls are active in the same field as Capsugel.